非艾滋病定义癌症对HIV感染者影响
综述阐述非艾滋病定义癌症已成为全球HIV感染者发病的重要来源,其中非病毒相关、与衰老相关的常见癌症(如前列腺癌)负担正超过病毒相关性癌症。衰老、行为及HIV特异性因素影响其发生与结局,尽管HIV感染者癌症结局较差,指南仍推荐标准治疗并强调抗逆转录病毒治疗与抗肿瘤药物相互作用管理,亟需治疗性试验改善结局。
要点
- 非艾滋病定义癌症疾病负担在HIV感染者中上升,非病毒相关衰老相关癌症负担超过病毒相关癌症。
- 指南推荐HIV合并非艾滋病定义癌症患者接受标准指南治疗,并密切管理抗逆转录病毒与抗肿瘤药物相互作用。
- 多数试验聚焦预防措施,亟需治疗性试验(含免疫治疗)改善HIV合并非艾滋病定义癌症结局。
核心结论
- 非艾滋病定义癌症是HIV感染者日益增加的发病来源,需治疗性试验改善结局。
研究设计与样本
- 综述,未报告系统检索范围与样本量。
主要发现
- HIV感染者非病毒相关、衰老相关常见癌症(如前列腺癌)负担正高于病毒相关性癌症。
- 大型人群研究显示HIV合并非艾滋病定义癌症患者癌症结局差于无HIV者。
- 衰老、行为及HIV特异性因素驱动非艾滋病定义癌症发生并影响结局。
关键数值与推荐
- 指南强调HIV合并非艾滋病定义癌症患者应接受标准、基于指南的治疗。
- 感染病与肿瘤科医生应密切合作处理抗逆转录病毒治疗与抗肿瘤治疗间潜在药物相互作用。
临床怎么用
- HIV合并非艾滋病定义癌症患者按指南接受标准抗肿瘤治疗。
- 感染科与肿瘤科协作管理抗逆转录病毒与抗肿瘤药物相互作用。
局限性
- 综述未报告系统检索策略与纳入研究数量。
- 缺乏治疗性试验证据,尤其免疫治疗在HIV合并非艾滋病定义癌症中的管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Non-AIDS-defining cancers are a growing source of morbidity for people with HIV globally. Although people living with HIV have a disproportionately increased risk of developing virally mediated cancers, cancer burden for common non-AIDS-defining cancers that are not virally associated and are linked to ageing, such as prostate cancer, is becoming higher than for virally mediated cancers. Ageing, behavioural, and HIV-specific factors drive the incidence and affect the outcomes of non-AIDS-defining cancers, presenting different challenges for addressing global morbidity and mortality from non-AIDS-defining cancer. Although large population-based studies have shown that people living with HIV with non-AIDS-defining cancers have poorer cancer outcomes than do people without HIV, current guidelines emphasise that people living with HIV with non-AIDS-defining cancers should receive standard, guideline-based treatment, and infectious disease and oncology providers should work closely to address potential drug interactions between antiretroviral therapy and antineoplastic treatment. Most trials target preventive measures focusing on non-AIDS-defining cancers. However, treatment trials for the optimal management of people living with HIV and non-AIDS-defining cancer, including interventions such as immunotherapies, are needed to improve non-AIDS-defining cancer outcomes.
引用
- Chiao EY, Coghill A, Kizub D, et al. The effect of non-AIDS-defining cancers on people living with HIV. Lancet Oncol. 2021. PMID: 34087151. doi:10.1016/S1470-2045(21)00137-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。